Methicillin-resistant Staphylococcus aureus (MRSA) in nursing homes: can an improvement in infection control practices decrease MRSA prevalence?
Completed
- Conditions
- Methicillin-resistant Staphyloccus aureus (MRSA) colonisationInfections and InfestationsMethicillin-resistant Staphyloccus aureus
- Registration Number
- ISRCTN79334890
- Lead Sponsor
- Queens University Belfast (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 66
Inclusion Criteria
Phase 1: all nursing homes in the Northern Board will be asked to participate. Within these homes, all residents and staff will be invited to participate.
Phase 2: For a nursing home to be considered in this phase, it must have at least 20 consenting adults.
Exclusion Criteria
Nursing home residents who are terminally ill, in a coma or not deemed fit to personally give consent and have no next-of-kin available to give consent, will be excluded from both phases of the trial. For staff, there are no specific exclusion criteria, other than failure to provide written informed consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method In phase 1, determination of MRSA prevalence in nursing homes in Northern Health and Social Services (NHSSB). In phase 2, the prevalence of MRSA in intervention homes compared to control homes following infection control intervention, audit and feedback.
- Secondary Outcome Measures
Name Time Method ot provided at time of registration